Thrombosis Research
Volume 125, Issue 3 , Pages 267-271 , March 2010

Markers of haemostasis and angiogenesis in placentae from gestational vascular complications: Impairment of mechanisms involved in maintaining intervillous blood flow

  • Elena Chinni

      Affiliations

    • Atherosclerosis and Thrombosis Unit, I.R.C.C.S. Casa Sollievo della Sofferenza, S.Giovanni Rotondo, FOGGIA, ITALY
    • ,
  • Donatella Colaizzo

      Affiliations

    • Atherosclerosis and Thrombosis Unit, I.R.C.C.S. Casa Sollievo della Sofferenza, S.Giovanni Rotondo, FOGGIA, ITALY
    • ,
  • Giovanni L. Tiscia

      Affiliations

    • Atherosclerosis and Thrombosis Unit, I.R.C.C.S. Casa Sollievo della Sofferenza, S.Giovanni Rotondo, FOGGIA, ITALY
    • ,
  • Pasquale Martinelli

      Affiliations

    • Obstetrics and Gynaecology, University Federico II, NAPLES, ITALY
    • ,
  • Giuseppe M. Maruotti

      Affiliations

    • Obstetrics and Gynaecology, University Federico II, NAPLES, ITALY
    • ,
  • Maria Matteo

      Affiliations

    • Obstetrics and Gynaecology, University of Foggia, FOGGIA, ITALY
    • ,
  • Maurizio Margaglione

      Affiliations

    • Atherosclerosis and Thrombosis Unit, I.R.C.C.S. Casa Sollievo della Sofferenza, S.Giovanni Rotondo, FOGGIA, ITALY
    • Medical Genetics, University of Foggia, FOGGIA, ITALY
    • ,
  • Elvira Grandone

      Affiliations

    • Atherosclerosis and Thrombosis Unit, I.R.C.C.S. Casa Sollievo della Sofferenza, S.Giovanni Rotondo, FOGGIA, ITALY
    • Corresponding Author InformationCorresponding author. Atherosclerosis and Thrombosis Unit, I.R.C.C.S. “Casa Sollievo della Sofferenza”, Poliambulatorio Giovanni Paolo II, S. Giovanni Rotondo (FG), ITALY. Tel./fax: +39 0 882 416273.

Received 3 June 2009 ,Revised 24 September 2009 ,Accepted 25 September 2009.

References 

  1. Estellés A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, et al. Altered expression of plasminogen activator inibitor type 1 in placentae from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood. 1994;84:143–150
  2. Lanir N, Aharon A, Brenner B. Haemostatic mechanisms in human placenta. Best Pract Res Clin Haemat. 2003;16:183–195
  3. Chinni E, Colaizzo D, Margaglione M, Rubini C, D'Ambrosio RL, Giuliani F, et al. Correlation between factors involved in the local haemostasis and angiogenesis in term human placenta. Thromb Res. 2008;122:376–382
  4. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Preeclampsia is associated with reduced serum levels of placental growth factor. Am J Obstet Gynecol. 1998;179:1539–1544
  5. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160:1405–1423
  6. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?. J Clin Invest. 1997;99:2139–2151
  7. Fisher SJ. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol. 2004;2:53
  8. Wulff C, Weigand M, Kreienberg R, Fraser HM. Angiogenesis during primate placentation in health and disease. Reproduction. 2003;126:569–577
  9. Brosens I, Dixon HG, Robertson WB. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol. 1977;84:656–663
  10. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158:892–898
  11. Paladini D, Rustico M, Viora E, Giani U, Bruzzese D, Campogrande M, et al. Fetal size charts for the Italian population. Normative curves of head, abdomen and long bones. Prenat Diagn. 2005;25:456–464
  12. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology. 1986;118:1567–1582
  13. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-Ct method. Methods. 2001;25:402–408
  14. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the “chicken-and-egg” question?. Endocrinology. 2004;145:4835–4837
  15. Estelles A, Gilabert J, Grancha S, Yamamoto K, Thinnes T, España F, et al. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe pre-eclampsia. Thromb Haemost. 1998;79:500–508
  16. Bellart J, Gilabert R, Anglès A, Piera V, Miralles RM, Monasterio J, et al. Tissue factor levels and high ratio of fibrinopeptide A: D-Dimer as measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol. 1999;106:594–597
  17. Aharon A, Lanir N, Drugan A, Brenner B. Placental TFPI is decreased in gestational vascular complications and can be restored by maternal enoxaparin treatment. J Thromb Haemost. 2005;3:2355–2357
  18. Aharon A, Brenner B, Katz T, Miyagi Y, Lanir N. Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental haemostasis. Thromb Haemost. 2004;92:776–786
  19. Ogawa M, Yanoma S, Nagashima Y, Okamoto N, Ishikawa H, Haruki A, et al. Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key. Placenta. 2007;28:224–232
  20. Kanfer A, Bruch JF, Nguyen G, He CJ, Delarue F, Flahault A, et al. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia. Lab Invest. 1996;74:253–258
  21. Kaetzel MA, Hazarika P, Dedman JR. Differential tissue expression of three 35-kDa annexin calcium-dependent phospholipid-binding proteins. J Biol Chem. 1989;264:14463–14470
  22. van Heerde WL, de Groot PG, Reutelingsperger CP. The complexity of the phospholipid binding protein Annexin V. Thromb Haemost. 1995;73:172–179
  23. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69:1–7
  24. Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab. 2003;88:5555–5563
  25. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol. 1998;179:1539–1544
  26. Ong CY, Liao AW, Cacho AM, Spencer K, Nicolaides KH. First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction. Obstet Gynecol. 2001;98:608–611
  27. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–683
  28. Geva E, Ginzinger DG, Zaloudek CJ, Moore DH, Byrne A, Jaffe RB. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab. 2002;87:4213–4224
  29. Kim I, Oh JL, Ryu YS, So JN, Sessa WC, Walsh K, et al. Angiopoietin-1 negatively regulates expression and activity of tissue factor inendothelial cells. FASEB J. 2002;16:126–128
  30. Dunk C, Shams M, Nijjar S, Rhaman M, Qiu Y, Bussolati B, et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol. 2000;156:2185–2199
  31. Athanassiades A, Hamilton GS, Lala PK. Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod. 1998;59:643–654

☆ From the Atherosclerosis and Thrombosis Unit, I.R.C.C.S. Casa Sollievo della Sofferenza, S.Giovanni Rotondo, FOGGIA, ITALY.

PII: S0049-3848(09)00417-4

doi: 10.1016/j.thromres.2009.09.024

Thrombosis Research
Volume 125, Issue 3 , Pages 267-271 , March 2010

Article Tools